Download our latest Progress Report! As this week marks #WAAW2022, the report emphasises a #OneHealth approach to the drivers and implications of #AMR and the associated #ESG risks. Download the full report: https://t.co/qQjZwcKIDj. @FAIRRInitiative@AtMIndex @PRI_News @DHSCgovuk
A serious reminder of the dangers of #AMR as tests discover that more than 10% of sampled #pork products are infected with bacteria resistant to “last resort” #antibiotic used to treat serious illnesses in humans.
Find details in a piece by @guardian at https://t.co/GfJvtczwqm.
We're announcing £4.5 million funding for research & development of innovative new treatments for drug-resistant infections identified by @WHO as the greatest threats to global health.
See how the UK’s taking action to tackle #AntimicrobialResistance 🔻
https://t.co/Adow302Xcg
On March 30, 2022, Swesif held an insightful webinar to illustrate the risks of #AMR but also the opportunities that exist to mitigate it and how investors and corporations are working to address the topic.
Watch the recording now at https://t.co/Lh7wLul5OH!
Exciting news as the UK is set to become the first country in the world to pay drug companies a fixed fee for supplying #antibiotics in an effort to tackle the global antimicrobial resistance #AMR crisis!
More details in a piece by @FinancialTimes at https://t.co/MyDzyQ8Q8F.
A powerful reminder about the dangers of #AMR in our #food chain as an investigation by @TBIJ finds that between 2015 and 2020, US companies sold products contaminated with campylobacter and salmonella - antibiotic resistant superbugs which can be fatal: https://t.co/eqbWNE10EO.
A great piece by our trusted partner, Prof. Dame Sally Davies @UKAMREnvoy, in @FinancialTimes exploring the risks to global health brought on by the #AMR crisis and stressing the urgency to act on the silent pandemic now.
Head to https://t.co/hpyOLx8oOz to read in full.
We are proud to welcome the GRAM report published in @TheLancet this month. The findings offer the most comprehensive estimates of the impact of the global #AMR crisis exposing how it is accelerating at an alarming rate.
Find our full statement at https://t.co/ExB9xGFZoe.
We are proud to share our response letter welcoming the #G7 Finance Ministers’ Statement on Actions to Support Antibiotic Development and highlighting our support of the G7 Finance Track in addressing antimicrobial resistance.
Read the letter in full at https://t.co/6RfJmvhyFK
Investor Action on AMR is thrilled to be acknowledged by the #G7 Finance Ministers in their latest statement, which recognises our important work and the essential role of investors in the fight against #AMR.
Head to https://t.co/Msj71SortC to read the statement in full.
Join @FAIRRInitiative, @PRI_News and @AtMIndex tomorrow 18 Nov at 2 p.m. GMT for a discussion on the health and economic costs of anti-microbial resistance and the key gaps and focus areas for the years ahead!
Register at https://t.co/VTgDJZJJij.
#AMR#WAAW#animalhealth
Really important to see this clear & direct statement from @WHO calling for an urgent reduction in antimicrobials used in #foodsystems: https://t.co/fyredQSDS6
Currently, more than 2/3 of all #antimicrobials worldwide are used in agriculture, posing a huge #AMR risk factor.
Important new report out by @UKAMREnvoy & @ClaireAOxlade outlining how, where and why research into #AMR should be intensified so as to mitigate & contain the #silentpandemic, w an emphasis on a #OneHealth approach.
Read it online now: https://t.co/nL2jHRTQ3b
#AMR is often treated as a future #publichealth crisis, something that needs to be defused today to protect the patients of tomorrow.
But what effects of AMR can already be felt today?
Find out in this engaging & concerning new report:
Interesting & entirely new sector to consider in fight against #AMR: raw dog food.
Read more about this surprising new research, which reiterates the urgency for a #OneHealth approach to this #publichealth crisis: https://t.co/uX4sQGZZVQ
'This leadership is critical for sending a clear message to producers that use of medically important antibiotics needs to end in order to prevent the next pandemic.'
Great to see Wendy's making sector leading commitments on antibiotic use: https://t.co/EIwKSJSOE1
Good afternoon & Welcome to the #AMRchat!
We will discuss how antimicrobial resistance (#AMR) & #antibioticresistance develop & impact patients; the intersection of AMR, COVID-19 & the #PASTEURAct—bipartisan legislation in Congress!
Let’s start off with introductions.
'SMEs now account for 75% of all late-stage antibiotics in the R&D pipeline'
Excellent new report highlights the need to support small & medium sized enterprises produce their vital new #antibiotics given a hostile economic environment: https://t.co/6ZUG8jKwhe
For investors wishing to learn more about AMR, what’s urgently need to fix #antibiotic market failures + how some #biotechs are finding new ways to bring life-saving #meds to those who need them: @ATMIndex’s new report is a great place to start https://t.co/Gxo6WZsrWj
#superbugs